Literature DB >> 24044895

Selective cytotoxicity, inhibition of cell cycle progression, and induction of apoptosis in human breast cancer cells by sesquiterpenoids from Inula lineariifolia Turcz.

Jiang-Jiang Qin1,2, Hui-Zi Jin1, Ying Huang1, Shou-De Zhang1, Lei Shan3, Sukesh Voruganti2, Subhasree Nag2, Wei Wang2, Wei-Dong Zhang1,3, Ruiwen Zhang2.   

Abstract

Four new sesquiterpenoid dimers (lineariifolianoids E-H, 1-4), five new sesquiterpenoids (5-9), and seven known sesquiterpenoids (10-16) were isolated from the aerial parts of Inula lineariifolia Turcz. Their structures were determined by spectroscopic data analysis and X-ray diffraction studies. The compounds were then evaluated for their in vitro cytotoxicity against two human breast cancer cell lines (MCF-7 and MDA-MB-231) and one normal breast cell line (MCF-10A). Lineariifolianoid E (1) showed IC50 values of 1.56 μM and 2.75 μM against MCF-7 and MDA-MB-231, respectively. However, lineariifolianoid E demonstrated low toxicity to MCF-10A cells, which indicated a selective cytotoxicity for tumor cells. Further studies also presented that lineariifolianoid E had significant, dose-dependent effects on cell cycle progression and apoptosis in breast cancer cells.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Apoptosis; Breast cancer; Cell cycle arrest; Cytotoxicity; GNGQKLZFBUPHJG-XISWFLCMSA-N; Inula lineariifolia Turcz.; JRTIKBMBXBPGNG-XFGMNWCASA-N; MBMTVBZMAJEBHZ-RUQFOMCVSA-N; OJVIJEPDCXTKTE-SJRFUVFFSA-N; RBLYUGWIFLXCPD-CDWXYHGHSA-N; RYPWQIGVZVKJLS-OOUKEXCNSA-N; Sesquiterpenoid; WCZBMGWSWYHCAA-PDNFSXIVSA-N

Mesh:

Substances:

Year:  2013        PMID: 24044895      PMCID: PMC4094229          DOI: 10.1016/j.ejmech.2013.07.018

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  34 in total

1.  A sesquiterpenelactone from Inula britannica induces anti-tumor effects dependent on Bcl-2 phosphorylation.

Authors:  Mohamed M Rafi; Nai-Sheng Bai; Robert T Rosen; Eileen White; Denise Perez; Robert S Dipaola
Journal:  Anticancer Res       Date:  2005 Jan-Feb       Impact factor: 2.480

2.  Sesquiterpene lactones from Inula falconeri, a plant endemic to the Himalayas, as potential anti-inflammatory agents.

Authors:  Xiangrong Cheng; Qi Zeng; Jie Ren; Jiangjiang Qin; Shoude Zhang; Yunheng Shen; Jiaxian Zhu; Fei Zhang; Ruijie Chang; Yan Zhu; Weidong Zhang; Huizi Jin
Journal:  Eur J Med Chem       Date:  2011-09-08       Impact factor: 6.514

Review 3.  What made sesquiterpene lactones reach cancer clinical trials?

Authors:  Akram Ghantous; Hala Gali-Muhtasib; Heikki Vuorela; Najat A Saliba; Nadine Darwiche
Journal:  Drug Discov Today       Date:  2010-06-09       Impact factor: 7.851

4.  Two new eudesmanolides from Inula racemosa.

Authors:  Ting Zhang; Wei Xiao; Ting Gong; Yan Yang; Ruo-Yun Chen; De-Quan Yu
Journal:  J Asian Nat Prod Res       Date:  2010-09       Impact factor: 1.569

5.  New sesquiterpene dimers from Inula britannica inhibit NF-kappaB activation and NO and TNF-alpha production in LPS-stimulated RAW264.7 cells.

Authors:  Hui Zi Jin; Dongho Lee; Jeong Hyung Lee; Kyeong Lee; Young-Soo Hong; Dong-Ho Choung; Young Ho Kim; Jung Joon Lee
Journal:  Planta Med       Date:  2006-01       Impact factor: 3.352

6.  Hepatoprotective effects of Inula britannica on hepatic injury in mice.

Authors:  Q H Song; T Kobayashi; K Iijima; T Hong; J C Cyong
Journal:  Phytother Res       Date:  2000-05       Impact factor: 5.878

7.  Sesquiterpenoids from Inula lineariifolia inhibit nitric oxide production.

Authors:  Li-Yue Nie; Jiang-Jiang Qin; Ying Huang; Lan Yan; Yu-Bo Liu; Yue-Xing Pan; Hui-Zi Jin; Wei-Dong Zhang
Journal:  J Nat Prod       Date:  2010-06-25       Impact factor: 4.050

8.  Sesquiterpene antitumor agents: inhibitors of cellular metabolism.

Authors:  K H Lee; I H Hall; E C Mar; C O Starnes; S A ElGebaly; T G Waddell; R I HADGRAFT; C G Ruffner; I Weidner
Journal:  Science       Date:  1977-04-29       Impact factor: 47.728

9.  In vitro and in vivo anticancer activity of novel synthetic makaluvamine analogues.

Authors:  Wei Wang; Elizabeth R Rayburn; Sadanandan E Velu; Dwayaja H Nadkarni; Srinivasan Murugesan; Ruiwen Zhang
Journal:  Clin Cancer Res       Date:  2009-05-15       Impact factor: 12.531

10.  Japonicones A-D, bioactive dimeric sesquiterpenes from Inula japonica Thunb.

Authors:  Jiang Jiang Qin; Hui Zi Jin; Jian Jun Fu; Xiao Jia Hu; Yan Wang; Shi Kai Yan; Wei Dong Zhang
Journal:  Bioorg Med Chem Lett       Date:  2008-12-14       Impact factor: 2.823

View more
  8 in total

1.  Oral delivery of anti-MDM2 inhibitor SP141-loaded FcRn-targeted nanoparticles to treat breast cancer and metastasis.

Authors:  Jiang-Jiang Qin; Wei Wang; Sushanta Sarkar; Ruiwen Zhang
Journal:  J Control Release       Date:  2016-07-06       Impact factor: 9.776

Review 2.  A Review of Twenty Years of Research on the Regulation of Signaling Pathways by Natural Products in Breast Cancer.

Authors:  Muhammad Naeem; Muhammad Omer Iqbal; Humaira Khan; Muhammad Masood Ahmed; Muhammad Farooq; Muhammad Moeen Aadil; Mohamad Ikhwan Jamaludin; Abu Hazafa; Wan-Chi Tsai
Journal:  Molecules       Date:  2022-05-25       Impact factor: 4.927

Review 3.  Perspectives on natural compounds in chemoprevention and treatment of cancer: an update with new promising compounds.

Authors:  Abedul Haque; Daniel Brazeau; Arm R Amin
Journal:  Eur J Cancer       Date:  2021-04-14       Impact factor: 9.162

4.  Identification of lineariifolianoid A as a novel dual NFAT1 and MDM2 inhibitor for human cancer therapy.

Authors:  Jiang-Jiang Qin; Sushanta Sarkar; Sukesh Voruganti; Rajesh Agarwal; Wei Wang; Ruiwen Zhang
Journal:  J Biomed Res       Date:  2016-05-25

5.  Inhibiting NFAT1 for breast cancer therapy: New insights into the mechanism of action of MDM2 inhibitor JapA.

Authors:  Jiang-Jiang Qin; Wei Wang; Sukesh Voruganti; Hui Wang; Wei-Dong Zhang; Ruiwen Zhang
Journal:  Oncotarget       Date:  2015-10-20

6.  Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action.

Authors:  Sukesh Voruganti; Jiang-Jiang Qin; Sushanta Sarkar; Subhasree Nag; Ismail A Walbi; Shu Wang; Yuqing Zhao; Wei Wang; Ruiwen Zhang
Journal:  Oncotarget       Date:  2015-08-28

Review 7.  The Role of Autophagy in Gastric Cancer Chemoresistance: Friend or Foe?

Authors:  Jing-Li Xu; Li Yuan; Yan-Cheng Tang; Zhi-Yuan Xu; Han-Dong Xu; Xiang-Dong Cheng; Jiang-Jiang Qin
Journal:  Front Cell Dev Biol       Date:  2020-12-03

8.  Targeting E2 ubiquitin-conjugating enzyme UbcH5c by small molecule inhibitor suppresses pancreatic cancer growth and metastasis.

Authors:  Simin Qi; Xiaoqing Guan; Jia Zhang; Dehua Yu; Xuefei Yu; Qinglin Li; Wenjuan Yin; Xiang-Dong Cheng; Weidong Zhang; Jiang-Jiang Qin
Journal:  Mol Cancer       Date:  2022-03-10       Impact factor: 27.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.